Cargando…
Treatment of Obesity and Diabetes Using Oxytocin or Analogs in Patients and Mouse Models
Obesity is important for the development of type-2 diabetes as a result of obesity-induced insulin resistance accompanied by impaired compensation of insulin secretion from pancreatic beta cells. Here, based on a randomized pilot clinical trial, we report that intranasal oxytocin administration over...
Autores principales: | Zhang, Hai, Wu, Chenguang, Chen, Qiaofen, Chen, Xiaoluo, Xu, Zhigang, Wu, Jing, Cai, Dongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658979/ https://www.ncbi.nlm.nih.gov/pubmed/23700406 http://dx.doi.org/10.1371/journal.pone.0061477 |
Ejemplares similares
Cargando…
Oxytocin: A Potential Therapeutic for Obesity
por: Hong, Soo Min, et al.
Publicado: (2021)
por: Hong, Soo Min, et al.
Publicado: (2021)
Ejemplares similares
-
Oxytocin as an Anti-obesity Treatment
por: Niu, JingJing, et al.
Publicado: (2021) -
Deregulation of lncRNA HIST1H2AG-6 and AIM1-3 in peripheral blood mononuclear cells is associated with newly diagnosed type 2 diabetes
por: Jiang, Hui, et al.
Publicado: (2021) -
Oxytocin and cardioprotection in diabetes and obesity
por: Jankowski, Marek, et al.
Publicado: (2016) -
Oxytocin receptors in the Magel2 mouse model of autism: Specific region, age, sex and oxytocin treatment effects
por: Gigliucci, Valentina, et al.
Publicado: (2023) -
Oxytocin in metabolic homeostasis: implications for obesity and diabetes management
por: Ding, C., et al.
Publicado: (2018)